| scholarly article | Q13442814 |
| P2093 | author name string | Liesbeth Hameetman | |
| Anne-Marie Cleton-Jansen | |||
| Pancras C W Hogendoorn | |||
| Judith V M G Bovée | |||
| Anthonie H M Taminiau | |||
| Leida B Rozeman | |||
| P2860 | cites work | Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development | Q24315654 |
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein | Q28137935 | ||
| Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature. | Q33765771 | ||
| A mutant PTH/PTHrP type I receptor in enchondromatosis | Q34521165 | ||
| Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. | Q34552391 | ||
| Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors | Q41537181 | ||
| Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. | Q43996886 | ||
| Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. | Q44001166 | ||
| EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast | Q44490794 | ||
| Expression of cartilage growth plate signalling molecules in chondroblastoma. | Q44705491 | ||
| P433 | issue | 4 | |
| P921 | main subject | chondrosarcoma | Q1076087 |
| P304 | page(s) | 476-482 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas. | |
| P478 | volume | 205 |
| Q37150809 | Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma |
| Q38312291 | Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. |
| Q34454218 | BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors |
| Q58705635 | Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma |
| Q37740672 | Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma |
| Q42542315 | CORR Insights®: Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones? |
| Q37763842 | Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. |
| Q35832096 | Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix |
| Q35841926 | Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro |
| Q34591289 | Chondrosarcoma: with updates on molecular genetics |
| Q35070800 | Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation |
| Q84522319 | Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes |
| Q37281697 | Destabilization of the IFT-B cilia core complex due to mutations in IFT81 causes a Spectrum of Short-Rib Polydactyly Syndrome |
| Q53574637 | Differential expression of runx2 and Indian hedgehog in cartilaginous tumors. |
| Q36212898 | Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment |
| Q38434804 | Exploring the key genes and pathways in enchondromas using a gene expression microarray |
| Q35668685 | FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling |
| Q53070824 | Genetic alterations in chondrosarcomas - keys to targeted therapies? |
| Q41259136 | Identification of novel biomarker candidates for immunohistochemical diagnosis to distinguish low-grade chondrosarcoma from enchondroma |
| Q36676500 | Loss of β-catenin induces multifocal periosteal chondroma-like masses in mice |
| Q38588243 | Molecular basis of differentiation therapy for soft tissue sarcomas |
| Q36613603 | Molecular pathology of chondroid neoplasms: part 1, benign lesions |
| Q36078319 | No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone |
| Q37294776 | PTHR1 mutations associated with Ollier disease result in receptor loss of function |
| Q41330027 | Patched-one or smoothened gene mutations are infrequent in chondrosarcoma |
| Q37457708 | Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. |
| Q37185828 | Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells |
| Q42677448 | TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells |
| Q88167587 | Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation |
| Q36392814 | Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist |
| Q59196037 | The Role of EXT1 in Nonhereditary Osteochondroma: Identification of Homozygous Deletions |
| Q53547784 | The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibroma. |
Search more.